Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2012 | 12-2011 | 01-2011 | 12-2010 | 01-2010 | |
| Sales | 29,607 | 161 | 29,618 | 135 | 31,136 |
| Cost of Goods | 21,112 | 1,043 | 20,486 | 1,341 | 20,268 |
| Gross Profit | 8,495 | -882 | 9,132 | -1,206 | 10,868 |
| Operating Expenses | 7,266 | 13,456 | 7,901 | 15,522 | 6,993 |
| Operating Income | 1,341 | -14,295 | 1,717 | -16,387 | 4,143 |
| Interest Expense | 371 | 41 | 745 | 11 | 602 |
| Other Income | -142 | 5,321 | 108 | 3,262 | 548 |
| Pre-tax Income | 828 | -9,015 | 1,080 | -13,136 | 4,089 |
| Income Tax | 436 | N/A | 455 | N/A | -172 |
| Net Income Continuous | 392 | -9,015 | 625 | -13,136 | 4,261 |
| Net Income | $392 | $-9,015 | $625 | $-13,136 | $4,261 |
| EPS Basic Total Ops | 0.10 | -3,701.92 | 0.17 | -5,288.46 | 1.15 |
| EPS Basic Continuous Ops | 0.10 | -3,520.25 | 0.17 | -5,183.57 | 1.15 |
| EPS Diluted Total Ops | 0.10 | -3,701.92 | 0.15 | -5,288.46 | 1.09 |
| EPS Diluted Continuous Ops | 0.10 | -3,520.25 | 0.15 | -5,183.57 | 1.09 |
| EBITDA(a) | $1,918 | $-13,665 | $2,516 | $-15,607 | $4,954 |